External fixation

Titanium Emerges as the Dominant Material in Trauma Fixation Devices, Backed by Biocompatibility and Strength-to-Weight Ratio - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 19, 2023

Trauma fixation devices, a crucial component of trauma care, play a vital role in the treatment of bone fractures and tissue degeneration.

Key Points: 
  • Trauma fixation devices, a crucial component of trauma care, play a vital role in the treatment of bone fractures and tissue degeneration.
  • These incidents often result in bone fractures and dislocations, necessitating the use of trauma fixation devices for the repair of bone-related deformities.
  • Internal fixators, which play a crucial role in orthopedic and trauma surgeries for stabilizing bones and tissues, dominate the trauma fixation devices market.
  • In terms of material, the Trauma Fixation Devices Market is divided into Stainless Steel, Titanium, and Others.

Global Lower Extremities Trauma Devices Markets, Competitional Forecast and Opportunities, 2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 19, 2022

Global lower extremities trauma devices market is anticipated to grow at a significant rate during the forecast period.

Key Points: 
  • Global lower extremities trauma devices market is anticipated to grow at a significant rate during the forecast period.
  • Besides, rising cases of road accidents and injuries worldwide and rising awareness for the trauma devices are expected to propel the growth of the global lower extremities trauma devices market.
  • Consistent influx of new technologies and introduction of newer devices are anticipated to drive the global lower extremities trauma devices market.
  • The global lower extremities trauma devices market segmentation is based on type, site, end user, regional distribution, and competitive Landscape.

Issuance of patents for the SixFix® Circular Fixation System and the AMDT Mini-Rail Fixator System

Retrieved on: 
Tuesday, January 4, 2022

6966460 from the Japanese Patent Office, for patents on its SixFixCircular Fixation System.

Key Points: 
  • 6966460 from the Japanese Patent Office, for patents on its SixFixCircular Fixation System.
  • CN109462978 on the AMDT Mini-Rail Fixator System.
  • AMDT Holdings currently has over 40 patent applications pending in the United States, Europe, Australia, Brazil, Canada, Japan and China covering the many novel and unique design aspects of the SixFix External Fixation System Hardware, the SixFix Deformity Analysis & Correction Software and the AMDT Mini-Rail Fixator System.
  • In 2022, AMDT Holdings will continue to aggressively add to its robust portfolio of pending U.S. and foreign patent applications to further expand protection for its newly developed External Fixation technology.

Outlook on the Trauma Fixation Devices Global Market to 2027 - Increase in the Prevalence of Road Accidents is the Main Driving Factor - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 19, 2021

Increase in prevalence of road accidents is the main driving factor which is expected to boost the global trauma fixation devices market growth.

Key Points: 
  • Increase in prevalence of road accidents is the main driving factor which is expected to boost the global trauma fixation devices market growth.
  • Further, increase in incidences of bone degenerative diseases will have the positive impact on global trauma fixation devices market growth.
  • Moreover, Rise in technical advancements and innovations in medical devices industry which are expected to fuel the global trauma fixation devices market growth.
  • However, lack of trained professional is the restraining factor which is expected to hamper the global trauma fixation devices market growth.

Global Trauma Devices Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on: 
Friday, August 13, 2021

The "Trauma Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Trauma Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Trauma Devices, estimated at US$7.5 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.9% over the period 2020-2027.
  • Internal Fixators, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$6.2 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 7.6% CAGR
    The Trauma Devices market in the U.S. is estimated at US$2 Billion in the year 2020.

Global Trauma Fixation Devices Pipeline Assessment Report 2020 Featuring 100+ Companies/Universities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 14, 2021

b'The "Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com\'s offering.\n"Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Trauma Fixation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.\nTrauma Fixation devices are used for the treatment of fractures.

Key Points: 
  • b'The "Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com\'s offering.\n"Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Trauma Fixation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.\nTrauma Fixation devices are used for the treatment of fractures.
  • These devices provide support for aligning, stabilizing and immobilization of fractured bones.
  • Trauma fixation devices are broadly classified into two types - Internal Fixators and External Fixators.\nThe report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities\nIn-depth analysis of the product\'s current stage of development, territory and estimated launch date\n'

RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology

Retrieved on: 
Tuesday, April 6, 2021

"Based on what I've seen, the ability to treat this common fracture safely by percutaneous means could significantly improve the way these fractures are treated."

Key Points: 
  • "Based on what I've seen, the ability to treat this common fracture safely by percutaneous means could significantly improve the way these fractures are treated."
  • Fractures to the major wrist bone, called the radius, are one of the most common orthopaedic injuries.Each year more than 675,000 American suffer from a distal radius fracture.
  • "This opportunity really showcases the reason we invented this productto provide surgeons with a first ever regenerative bone adhesive," said Brian Hess, CEO of RevBio.
  • "This is the first of many indications we intend to launch to revolutionize how bone fractures are treated."

Able Medical Devices Announces FDA Clearance of Valkyrie™ Thoracic Fixation System

Retrieved on: 
Tuesday, March 9, 2021

Able Medical Devices, Inc. (Able) today announced the U.S. FDA 510(k) clearance of the Valkyrie Thoracic Fixation System.

Key Points: 
  • Able Medical Devices, Inc. (Able) today announced the U.S. FDA 510(k) clearance of the Valkyrie Thoracic Fixation System.
  • Valkyrie is intended for use in the stabilization and fixation of fractures of the chest wall, including sternal fixation following sternotomy, as well as sternal reconstructive surgical procedures for patients with normal and/or poor bone.
  • View the full release here: https://www.businesswire.com/news/home/20210309005279/en/
    The Valkyrie Thoracic Fixation System features the clinically proven performance of rigid fixation combined with the use of novel materials and the benefits of bioactive science to maximize sternal stability and promote bone healing.
  • Able Medical Devices is a leader in contract manufacturing and development.

Notice of Allowance issued for one of several pending patent applications for the SixFix® Circular Fixator

Retrieved on: 
Friday, November 6, 2020

COLLIERVILLE, Tenn., Nov. 6, 2020 /PRNewswire/ --AMDT Holdings, Inc. is pleased to announce the recent issuance of a Notice of Allowance from the United States Patent and Trademark Office for one of its several pending patent applications on its SixFix Circular Fixator.When this patent issues it will join a growing portfolio of other AMDT US and foreign patents that protect the SixFix Circular Fixator, the SixFix Deformity Analysis and Correction Software and the AMDT Mini-Rail Fixator System.

Key Points: 
  • COLLIERVILLE, Tenn., Nov. 6, 2020 /PRNewswire/ --AMDT Holdings, Inc. is pleased to announce the recent issuance of a Notice of Allowance from the United States Patent and Trademark Office for one of its several pending patent applications on its SixFix Circular Fixator.When this patent issues it will join a growing portfolio of other AMDT US and foreign patents that protect the SixFix Circular Fixator, the SixFix Deformity Analysis and Correction Software and the AMDT Mini-Rail Fixator System.
  • AMDT Holdings continues to aggressively add to its stable of pending US and foreign patent applications to expand its protective reach as new commercial developments supplement its family of External Fixation products.
  • To learn more about AMDT and our technologies, please visit www.AMDTHoldings.com .

FDA Clearance Granted to WishBone Medical’s Pediatric External Fixation System

Retrieved on: 
Tuesday, October 13, 2020

WARSAW, Ind., Oct. 13, 2020 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance on their Smart Correction External Fixation System, which comprises hexapod external fixator hardware and proprietary planning software.

Key Points: 
  • WARSAW, Ind., Oct. 13, 2020 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance on their Smart Correction External Fixation System, which comprises hexapod external fixator hardware and proprietary planning software.
  • Looking forward, WishBone will ultimately transition the System to single-use, sterile packed procedure kits.
  • The WishBone Medical Smart Correction System is a hexapod external fixator used to stabilize and maintain alignment of complicated fractures, soft tissues and/or congenital deformity repairs.
  • External fixation in children is a large and growing area, and WishBone Medical has the most advanced software and hardware available.